Skip to main content
Log in

RSV in young children imposes substantial economic burden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 euros

Reference

  • Zhang S, et al. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. Journal of Infectious Diseases : 30 Mar 2020. Available from: URL: http://doi.org/10.1093/infdis/jiz683

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

RSV in young children imposes substantial economic burden. PharmacoEcon Outcomes News 851, 35 (2020). https://doi.org/10.1007/s40274-020-6758-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6758-9

Navigation